US FDA Indications for Use: The device is intended to emit energy in the visible and infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of muscle and joint pain and stiffness, minor arthritis pain, or muscle spasm; the temporary increase in local blood circulation; and/or the temporary relaxation of muscle. Health Canada license: EMVITAL is a non-invasive therapeutic device indicated for emitting energy in 

the infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for temporary relief of minor muscle and joint pain, muscle spasm, pain and stiffness associated with arthritis, inflammatory conditions 

as tenosynovitis, bursitis, synovitis and chronic inflammatory pelvic diseases, promoting relaxation of the muscle tissue, and to temporarily increase local blood circulation.

© BTL Group of Companies. BTL® and EMVITAL® are trademarks or registered trademarks in the United States, Canada and the European Union.